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Background 
Obstructive sleep apnea (OSA) is a condition characterized by 20-40 second episodes of 
breathing cessation during sleep. The hard palate serves as both the roof of the oral cavity and the 
floor of the nasal cavity. Constriction of the palate can have profound effects on the passage of 
oxygen into the lungs. Polysomnography is the gold standard test for detection of the presence and 
severity of obstructive sleep apnea. Recently, a home sleep testing device known as the WatchPAT 
has been implemented as an adjunctive test. This randomized controlled crossover trial will 
investigate the role of maxillary expansion in children at risk for OSA using the WatchPAT as the 
diagnostic tool. 
    Methods 
Twelve patients aged 12-16 without any medical syndromes were randomly assigned to 
either treatment or observation group. Pre-treatment (T1) records were taken on all patients. 
Treatment group was fitted with bonded type, rapid maxillary expanders and treated for three 
months according to an expansion protocol utilized by the private practice of GKG Orthodontics. 
A second WatchPAT study was performed at the completion of the three month period (T2). The 
treatment group was followed an additional three months without further expansion and a final T3 
WatchPAT study was performed. The control group had a T1 WatchPAT study followed by three 
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months of observation without expansion. A T2 study was performed at the end waiting period 
and then an expander was placed. The methodology then mirrored that of the treatment group.  
     Results 
Pre treatment AHI was found to be 2.47 episodes per hour for the treatment group. Post-
treatment AHI was found to be 2.10 episodes per hour. Pre-treatment snoring frequency was 
measured at 2.57 percent of the night before expansion therapy and 1.60 percent after treatment.   
   Conclusions 
AHI and snoring as measured by WatchPAT, decreased following expansion.  Initial 
analysis of this pilot study shows a positive effect of rapid maxillary expansion on sleep quality as 
measured by AHI and other parameters.  
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1.0 Background 
1.1 Sleep Architecture 
Sleep architecture refers to the basic organization pattern of sleep. There are two distinct 
forms of sleep; non-rapid eye movement (NREM), and rapid-eye movement (REM) (Loomis, 
1937). NREM is further divided into 4 distinct stages; 1, 2, 3, and 4 which denote increasing depth 
of sleep. NREM sleep constitutes about 80% of total sleep time, with REM sleep making up the 
last 20%. Each phase of sleep is readily differentiated from the next using electroencephalogram 
(EEG) recordings of brain activity (Dement, 1957).  
Humans do not remain in one stage of sleep for too long. Instead, we cycle from stage 1 
through stage 4 and then finally to REM sleep. This pattern repeats itself many times throughout 
the night and creates what sleep physicians call, a sleep cycle. A sleep cycle takes about 90 – 120 
minutes to complete (Zepelin, 2005).  
Stage 1 of NREM sleep serves a transitional role in sleep architecture. This stage usually 
lasts only 1 to 7 minutes and is easily disrupted by a loud noise, bright light, or other physical 
event. In total, stage 1 sleep only accounts for between 2 and 5 percent of sleep time (Carskadon, 
2005).  
A single cycle of stage 2 NREM sleep lasts 10-25 minutes during the first cycle and 
increases in length with each successive cycle; eventually constituting 45-55 percent of total sleep 
time (Carskadon, 2005). Stage 2 is a deeper level of sleep. Individuals in this stage require more 
forceful stimuli to be woken.  
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Stages 3 and 4 are referred to as slow wave sleep due to the high voltage, but slow wave 
activity present on EEG. Stage 3 sleep usually occurs only in the first third of the night. Cycles 
last only a few minutes and constitute only 3-8 percent of total sleep time. Sleep cycles in stage 4 
last 20-40 minutes and make up 10-15 percent of total sleep time (Carskadon, 2005). As the deepest 
stage of sleep, stage 4 requires the most extreme stimuli to be aroused.  
REM sleep is differentiated by rapid bursts of eye movements. The initial REM cycle only 
lasts 1-5 minutes; but it lengthens in later periods of the night (Carskadon, 2005). REM sleep is 
most associated with dreaming, as well as loss of muscle tone reflexes (Dement, 1957).  
1.2 Overview of Sleep-Related Breathing Disorders 
The International Classification of Sleep Disorders divides sleep related breathing 
disorders (SRBD) into three groups: central apnea syndromes, obstructive syndromes, and 
hypoventilation syndromes (AASM, 2005).  Obstructive sleep apnea is a sleep disorder that usually 
results from upper airway obstruction in both children and adults and causes episodes of complete 
or partial airway obstruction during sleep. It leads to increased respiratory effort, sleep 
fragmentation, and alterations of gas exchange and is associated with numerous sequelae, 
primarily involving the cardiovascular, metabolic and neurocognitive systems. Obstructive Sleep 
Related Breathing Disorders (SRBDs) are a continuum of sleep problems that encompass (in 
increasing severity); 
Primary snoring. Defined as more than 3 nights per week of snoring without any blood gas 
perfusion symptoms such as apneas, hypopneas, or arousals.  
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Upper airway resistance syndrome (UARS) includes primary snoring with increased work 
of breathing and arousals without gas exchange abnormalities.  
Obstructive sleep apnea syndrome includes recurrent or partial upper airway obstruction 
with disruption of normal blood oxygenation and sleep pattern.  (Marcus, 2012)  
1.3 Epidemiology 
Sleep problems rank fifth among the complaints reported to pediatricians by parents 
(Mindell, 2005). In line with this alarming statistic, it is not surprising to hear that up to 50% of 
children may experience a sleep problem (Owens, 2000).  OSA has a peak incidence around age 
2-8, most likely due to the excessive size of the lymphoid tissues in relation to the diameter of the
upper airway (Marcus, 2012). Figure 1 summarizes the available epidemiological research 
concerning OSA among different age groups and populations. Overall, the prevalence of OSA in 
children varies from 1-5% and is more common in males than females (Li, 2010) Some evidence 
exists that shows a predilection for Americans of African descent and those with obesity (Redline, 
1999). 
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1.4 Etiology and Risk Factors 
1.4.1 Anatomic Considerations 
Like many common medical conditions, OSA has a multifactorial etiology which includes 
anatomy, growth cycles, genetics, and bodyweight. Broadly speaking, OSA etiologies can be 
classified into conditions which narrow the upper airway and those that result in increased upper 
airway collapsibility, usually due to decreased muscle tone. (Paediatric Obstructive Sleep Apneoa, 
2010). In some subjects, the anatomy of the soft palate can contribute to the risk of OSA, as an 
increased dimension of the uvula and tongue, along with enlarged adenoids and tonsils can 
Figure 1: Prevalence of Chilhood OSA 
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predispose one to sleep-related breathing problems.. Tonsil and adenoid enlargement are very 
common in children. Removal is seen as first line treatment for childhood OSA (Vale, 2017). 
Figure 2: Effect of Micrognathia on the Airway 
The pharynx is a collapsible tube with a genetically set diameter (Huang, 2017). This 
diameter, however, can be strongly affected by aberrant anatomical growth patterns or 
obstructions. Some patients are born with an airway that is simply too small to support the 
functional needs of the individual. Obstruction can occur easily when the airway is diminutive due 
to midface hypoplasia or micrognathia of the mandible. The posterior positioning of these boney 
structures can impinge on the pharynx and decrease the space available for the airway (Figure 2).  
The most common anatomic cause of OSA in children is hypertrophy of the adenoids and 
tonsils. This tissue, collectively part of the lymphoid system, is largest between ages 2-8. The 
hypertrophy is coincident with the spike of the lymphoid growth curve and the spike in incidence 
of OSA (Jeans, 1981). 
6 
Nasal breathing can be affected by aberrant anatomy as well. A deviated septum can 
prevent adequate nasal breathing. The hard palate serves as both the roof of the oral cavity and the 
floor of the nasal cavity. It is hypothesized that constriction of the palate can have profound effects 
on the passage of oxygen through the nostrils and into the lungs. With constriction of the maxilla 
comes decreased total volume of the nasal passageways and a shift from nasal breathing to mouth 
breathing. Many studies involving lower levels of evidence have suggested a positive effect on 
sleep parameters after expansion of the maxillary bones with dental appliances. A systematic 
review and meta-analysis of 5 relevant publications evaluated the effect of rapid maxillary 
expansion on AHI. Results showed an overall reduction in AHI down to asymptomatic levels, and 
suggested use of RME on patients who do not respond well to adenotonsillectomy as well as the 
use of RME concurrently with adenotonsillectomy (Vale, 2017).  
Alternatively, OSA can be caused by conditions that lead to upper airway collapsibility 
(Huang, 2017). During inspiration, the diaphragm contracts producing a reduced pressure in the 
chest. As the pressure drops, the lungs expand and the negative pressure is transferred to the upper 
airway. The respiratory effort of the diaphragm leads to a collapsing force on the pharyngeal 
tissues. The negative pressure which leads to the collapse is called the pharyngeal critical pressure 
(Pcrit). Pcrit differs from individual to individual but is largely determined by anatomy, body 
weight, body position, sleep stage and alcohol consumption (Sullivan, 2014).  The pharyngeal 
muscles counteract this closing pressure by maintaining their tone throughout the inspiratory 
effort. During sleep, however, pharyngeal muscle tone rapidly decreases, increasing the 
collapsibility of the airway. REM sleep, in particular, is associated with the greatest drop in muscle 
tone (Huang, 2017).  
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1.4.2 Environmental Considerations 
Inflammatory conditions such as allergic rhinitis or asthma can cause upper airway edema 
and decreased airway volume. Alcohol consumption, especially at dinner or during the evening, 
relaxes pharyngeal dilator muscles which increases upper airway resistance. Inflammatory 
conditions increase snoring and sleep apnea duration in susceptible individuals (Sullivan, 2014). 
Smokers are also at increased risk of OSA. Available evidence points to current smokers being 2.5 
times more likely to have OSA than non-smokers (Kashyap, 2001). Medications which depress 
the respiratory drive can promote apneic episodes also. Muscle relaxants, sedative hypnotics, 
narcotics, and opioids all have a similar effect on OSA severity.  The depression of the respiratory 
centers and reflexes decreases ventilator drive and increases apnea duration. The associated 
respiratory muscle hypotonia tends to further intensify the problem (Lee-Chiong, 2009).  
1.4.3  Genetic Considerations 
A study by the Cleveland Family Society showed an increased risk of OSA among first 
degree relatives. The heritability of OSA is estimated to be 30%. Factors such as obesity, 
craniofacial morphology, and soft tissue characteristics play an important role in the genetic 
transmission of OSA (Redline, 1995). In genome studies, a link has been found between AHI and 
chromosome 2p, 19p, and 8q (Palmer, 2004). Anatomic features that lead to a narrowing of the 
upper airway can have a profound effect on the risk for OSA. Genetically predetermined dental 
conditions like micrognathia, macroglossia, and midface hypoplasia can all contribute to 
obstruction. Some clinical syndromes that result in these dental abnormalities have been associated 
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with OSAS including; Prader-Willi, Bechwith-Wiedemann, Pierre Robin, and others (Follmar, 
2011). A full list of medical conditions associated with OSA is listed below.  
 
Table 1: Medical Conditions Associated with OSA 
Craniofacial Syndromes  Crouzon Syndrome  
Aperts Syndrome  
Treacher Collins Syndrome 
Goldenhar Syndrome  
Pierre Robin Syndrome  
Neurologic Diseases  Arnold-Chiari Malformation  
Meningomyelocele 
Cerebral Palsy  
Duchenne Muscular Dystrophy  
Conditions with abnormal muscle tone  Down syndrome  
Prader-Willi Syndrome  
Hypothyroidism  
Conditions with reduced airway patency  Adenotonsillar hypertrophy  
Obesity  








Obesity is probably the most important risk factor for OSA , other than hypertrophy of the 
adenoids and tonsils. Obese individuals are more likely to have shorter sleep times and greater 
oxygen desaturation than non-obese ones. Each unit increase in BMI above the 50th percentile is 
associated with a 12% increased risk for OSA (Hannon, 2012). Obesity can contribute to OSA 
through many different mechanisms. Fatty infiltrates dispersed throughout the soft tissue can 
narrow the diameter of the airway. Similarly, excess visceral fat attached to the chest wall can 
reduce the area the lungs can expand into during inspiration. This leads to a decrease in lung 
functional residual capacity and increases susceptibility to hypoxia during sleep (Tan, 2013). A 
summary of OSA etiologies is listed below.  
Table 2: Summary of OSA Etiologies 
Anatomic Obstruction Adenotonsillar Hypertrophy 
Craniofacial Anomalies  
Hypertrophy of cervical lymphoid tissue 
Nasal Obstruction  
Neuromuscular dysfunction Congenital or acquired muscle hypertonia or 
hypotonia  
Obesity Upper airway fatty infiltrate  
Increased abdominal visceral fat  
Decreased lung functional capacity 
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Genetic Factors Ethnicity  
Genetic polymorphism  
Airway irritants (smoking) 
Family history  
Inflammation Rhinosinusitis  
Asthma  
Nasal polyps  
Increased systemic inflammation 
1.5 Symptoms of Obstructive Sleep Apnea 
1.5.1 Clinical Presentation 
The first clinical symptom of OSA in patients is likely to be snoring. The sound, often 
continuous and unbearable to a bed partner is the reason for the doctor's visit. Later, snoring can 
turn from a continuous noise to a pattern of interrupted silences and noises as the sufferer enters 
an apneic episode and is without air for some time (Paiva, 2014). Body position during sleep has 
a drastic effect on airway collapsibility and snoring. Sleeping on one’s back is associated with the 
highest risk of snoring, whereas sleeping on one’s side is associated with less incidence. While 
snoring is the main reason for consultation with a sleep physician, it is not the only symptom. 
Additional symptoms of OSA include hypersomnia manifested as easily falling asleep during 
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monotonous activities, dry mouth, nocturia, lack of concentration, hypertension and headaches. 
Table 3 includes many of the more commonly found symptoms in both adults and children (Au, 
2009).  
 
Table 3: Symptoms of OSA 
Daytime Symptoms  Nighttime Symptoms  
Daytime Sleepiness  
Difficulty awakening  
Headaches  
Hyponasal speech  









Mouth breathing  
Snorting and gasping  
Restless speech  
Diaphoresis  
Unusual sleep position  
Sleep terrors  
Sleep walking  
Frequent awakenings  
Nocturnal enuresis  
 
 
Excessive daytime sleepiness is a common complaint of OSA sufferers. This sleepiness 
can manifest in reduced performance during work or school, lack of the ability to concentrate, and 
even increased risk of automobile accidents. Most adult sufferers report excess daytime sleepiness. 
In children, daytime sleepiness is socially accepted and seen as normal. Because of this, OSA can 
remain undiagnosed for long periods of time. Whereas sleepiness is the symptom with the most 
logical biologic basis, in many children the opposite symptom can be seen more often: sleep- 
deprived children suffering from OSA commonly have hyperactivity (Paiva, 2014). Nocturia, or 
bedwetting, is also seen in children. An increase in negative thoracic pressure caused by OSA can 
compress the bladder and lead to symptoms (Jeyakumar, 2012). 
The open mouth posture adopted by patients to compensate for poor breathing can have 
effects on the dentition. The dental literature refers to this open mouth posture associated with 
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lymphoid hyperplasia or nasal obstruction, as adenoid facies. Adenoid facies has been vaguely 
defined as a long, thin face with malar hypoplasia, high-arched palate, narrow maxillary arch, and 
angle class II malocclusion (Elluru, 2005). With the mouth open due to obstruction, the tongue 
places less pressure on the palate. With the mouth in a chronically open position, the forces on the 
mandible, temporal-mandibular joint, and dental arches are altered. These small force changes are 
thought to lead to aberrant growth such as maxillary constriction, forward head posture, and an 
increase in vertical height of the lower face (Elluru, 2005). This open mouth posture can directly 
affect the dentition. Dry mouth and diffuse gingival inflammation can alter the color and texture 
of the gums and make the patient more prone to periodontal conditions (Kaur, 2018).  
 
1.5.2 Neurocognitive Abnormalities 
Clinical trials have elucidated the prevalence of memory and concentration problems, 
mood disturbances and fatigue in those suffering from OSA. In adults, OSA can lead to lack of 
concentration and poor performance at work. Without sleep, the risk of automobile accidents is 
high. In 2000, there were 800,000 OSA related car accidents in the United States. The real 
economic cost of these accidents, attributable to OSA, are 15.9 billion US dollars and 1400 lives 
lost. (Sassani, 2004).  
Neurocognitive abnormalities are most clearly seen in school-age children. Cognitive 
deficits associated with OSA include poor school performance, poor language skills, poor verbal 
skills, lower general intelligence, impaired ability to learn and ADHD-like symptoms. In a study 
of first grade children, OSA was shown to be disproportionally high in children ranked in the 
bottom 10% of the class (Gozal, 1998). A recent meta-analysis including 16 studies confirmed 
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clear links between OSA and poor academic performance for core academic domains related to 
language, arts, maths and science in school-aged children (Galland, 2015).  
In adults, OSA disrupts sleep form architecture leading to symptoms of excessive daytime 
sleepiness, especially at work or during monotonous activities. Children differ in that their sleep 
architecture is commonly preserved. Instead of presenting with the excessive sleepiness seen in 
adults, the opposite symptom, hyperactivity, can be seen. This leads to abnormally high levels of 
ADHD diagnosis in this population. Commonly, children with ADHD or other hyperactivity 
related disorders, simply have OSA and are not sleeping as much as they need (Khalyfa, 2012).   
Depression is much more common in OSA patients. 21-41% of those with OSA also have 
depression, compared to only 9% in non-apneic patients (Harris, 2009). This symptom of OSA is 
bidirectional. OSA is considered a risk factor for depression and depression is considered a risk 
factor for OSA. Clinically depressed patients commonly report symptoms of OSA which include 
sleepiness, fatigue, and lower quality of life. Treating OSA sometimes, but not always, cures 
depression (Harris, 2009).  
Even after successful treatment of OSA, the neurocognitive effects may persist. A study 
by George et.al in 1997 showed that adults who underwent 12 months of positive airway pressure 
treatment for their OSA improved greatly in their performance on driving simulators, but still 
performed lower than those without OSA (George, 1997). In children, verbal and visual learning 
seem to normalize after only a few weeks of OSA treatment. Other areas, such as math and 
perceptual ability show an initial improvement but do not rebound fully. Even after curing of the 
OSA this leaves children with decreased cognitive functioning overall, compared to controls 
(Ferini-Strambi, 2003).  
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1.6 Diagnosis  
1.6.1 Clinical Evaluation  
Those suspected of having OSA should undergo a physical exam with accompanying 
diagnostic tests. The clinical exam should include examination of bodyweight along with facial 
asymmetry or aberrations which predispose one to OSA. Men with waist measurements over 
102cm and women with waist measurements over 88cm are at increased risk for OSA (Fogelholm, 
2007). The nose and nostrils are evaluated for asymmetry, obstructions, septal deviation, and 
nostril collapse upon inhalation. The upper airways are similarly evaluated for size and shape. 
Enlarged tonsils and adenoids, along with enlarged uvula, tongue, or narrow palate are noted. A 
low soft palate, diagnosed via the Mallampatti classification (Figure 3), predisposes one to a 
physical obstruction likely to cause OSA (AASM, 2005). Tonsils are classified based on their 
degree of hypertrophy. Grade I tonsils are inside the tonsillar fossa and the posterior pharyngeal 
pillars. Grade II tonsils occupy 25% of the oropharynx. Grade III tonsils occupy 50% of the 
oropharynx and Grade IV tonsils at least 75% of the oropharynx and usually meet at the midline, 
severely limiting airflow (Brennan, 2017).  
 
1.6.2 Sleep Questionnaires  
Sleep questionnaires are useful tools for identifying those suspected of having sleep-related 
breathing disorders . Questionnaires serve as simple, cost-effective screening methods that can be 
given to large quantities of patients. Available questionnaires include the Stanford Sleepiness 
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Scale, Epworth Sleepiness Scale (ESS) and Pediatric Sleep Questionnaire (PSQ). The Stanford 
sleepiness scale is a basic introspective measurement of sleepiness that can alert a physician to an 
abnormality (Figure 4) (Maclean, 1992). The Epworth Sleepiness Scale (Figure 5) is an 8 question 
self-diagnostic survey.  Respondents are asked to rate, on a 4 point scale, their chances of falling 
asleep during different daily activities. The scale ranges from zero to 24 with higher numbers 
indicating an increased daytime sleepiness (Rosenthal, 2008). The Pediatric Sleep Questionnaire 
(Figure 6) is a 20 question series of yes/no answers that is filled out by the parent or guardian of a 
minor. Positive answers to 8 or more of the 20 questions indicates increased risk of OSA and 
warrants further diagnostic testing (Peña-Zarza, 2012).   
1.6.3 Polysomnography 
The clinical exam is but one small part of comprehensive  diagnosis. The gold standard test 
of sleep diagnosis was, is, and is likely to be remain polysomnography (PSG). PSG is used to 
definitively diagnose the presence of sleep problems and their severity. This hospital based 
diagnostic test consists of an EEG, electro-oculogram (EOG), electromyogram (EMG) of the 
mentalis muscle, nasal and oral airflow cannulas, pulse oximetry, microphone (to measure snoring 
in decibels), ECG, blood pressure, and end tidal PCO2. In clinical terms, the PSG measures sleep 
stage, sleep quantity and sleep quality. Full PSGs are labor and resource intensive. They require a 
private room in a hospital with full time monitoring by a nurse or other health care practitioner. 
The results of the test must then be sent to a qualified sleep physician for interpretation.  
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1.6.4 Adjunctive Tests 
Although PSG provides a comprehensive analysis of sleep parameters, the test has many 
drawbacks. Disadvantages include patient discomfort, high cost and the need for technical 
expertise to monitor and analyze the test. Watch Peripheral Arterial Tonometry (watchPAT) is a 
portable wrist- borne device that measures peripheral arterial blood volume changes, along with 
actigraphy to accurately record sleep parameters. The peripheral arterial volume changes in the 
fingertip have been shown to correlate well with sympathetic activation of the nervous system. 
Many research publications in the past decade have reported a strong relationship between 
sympathetic activation and rapid eye movement (REM) sleep and sleep stage (Yalamanchal, 
2013). The watchPAT is capable of measuring with high accuracy, the presence and quantity of 
apneic episodes measured by AHI. Additionally, PAT can be easily coupled with technologies that 
measure total sleep time (TST), body position, blood oxygen saturation, RDI, ODI, and other 
parameters.  
A systematic review and meta-analysis of available research comparing PSG and 
watchPAT showed a high correlation between the two tests. Comparison of AHI between the tests 
showed a correlation coefficient of r = 0.889. Comparison of the oxygen desaturation index (ODI) 
was shown to be r = 0.942. Overall, sensitivity was found to be 76.9% with specificity at 78.3% 
(Tanphaichitr, 2018). Another systematic review comparing at home sleep devices found a high 
specificity (96.05%) but a low sensitivity (67%) of PAT when measuring AHI score. Overall, they 
concluded that AHI can be underestimated in at-home sleep studies. The reasons for this include, 
(1) AHI is calculated using total recording time instead of total sleep time, (2) hypopneas resulting
in an arousal but not a desaturation are not scored, and (3) information concerning sleep 
architecture cannot be measured (Tan, 2015). The high specificity allows PAT to be used as a very 
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practical and accurate means of screening potential OSA patients. Because of its low sensitivity, 
if OSA is suspected in patients without positive PAT results, a polysomnography is still warranted. 
At this time, watchPAT has been validated and FDA approved for use in adults and in children 
above age 12.  
 
1.6.5 Diagnosis of Severity  
The American Association of Sleep Medicine has clear diagnostic criteria for OSA. These 
criteria include:  
1. At least one of the following: 
a. Patient complains of excessive daytime sleepiness, unintentional sleep episodes 
during daytime, fatigue, or insomnia.  
b. The patient wakes gasping for air or choking.  
c. The bed partner reports loud snoring or difficulty breathing at night.  
2. Polysomnography displays one or more of the following:  
a. Five or more scored apneas per hour for adults  
b. One or more scored apneas per hour for children  
c. 15 or more total scored apneic events during the sleep cycle  
3. The disorder is not better explained by another syndrome or condition (AASM, 2005) 
 
To better understand diagnosis of sleep disorders, an understanding of types of respiratory 
events is necessary. As defined by the American Association of Sleep Medicine, an apnea is a 
complete cessation of airflow lasting 10 seconds or longer. In contrast, a hypopnea is a partial 
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cessation of airflow characterized by a 30% or greater reduction in airflow or a 3% reduction in 
oxygen saturation. A respiratory effort related arousal (RERA) is a breathing event which does not 
meet the threshold of a hypopnea or apnea; but causes a patient arousal from sleep (AASM, 2005). 
The AHI or apnea hypopnea index is the most used sleep statistic for quantifying OSA 
severity. The AHI is a numerical measure of the number of apneas or hypopneas per hour of sleep 
(AASM, 2005). In adults, an AHI of less than 5 is thought to be harmless. An AHI of 5-15 per 
hour is consistent with mild OSA. An AHI of 15-30 is moderate OSA, and anything over 30 apneas 
per hour is considered severe OSA. Children differ slightly in that anything over 1 apnea per hour 
is considered abnormal (Mitchell, 2015).  
The most important problem with AHI is that it does not give any information concerning 
how much the oxygen saturation drops during a particular episode (Temirbekov, 2018). The AHI 
provides an accounting for how many times a patient stops breathing throughout a night but it does 
not correlate this with the severity of the drop in arterial oxygen content. The oxygen desaturation 
index (ODI) solves this problem by describing all events in which the blood oxygen saturation 
drops by more than 4% for longer than 10 seconds (Temirbekov, 2018).  
Another measure of apneic events is the respiratory disturbance index (RDI). This measure 
differs from the AHI in that it includes full apneas, hypopneas, and RERAs in its accounting 
(AASM, 2005). The RDI is a quantification of the total number of sleep events during the night.  
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1.7 Treatment 
1.7.1 Weight Loss 
As previously stated, obesity is probably the most significant risk factor for OSA. Every 
unit increase in BMI above the 50th percentile is associated with a 12% increased risk of OSA. 
First line treatment for many overweight patients is likely to be weight loss counseling. Data exists 
for the positive impact of weight loss treatment on OSA for adolescent and adult patients. In a 
study by Verhulst et.al., researchers showed a significant decrease in AHI after weight loss of at 
least 24 kg. All patients had at least a 30% decrease in AHI with some experiencing total 
resolution. Currently, there are no studies showing the effect of weight loss on younger children. 
(Verhulst, 2009).  
1.7.2 Surgery 
Adenoidectomy and tonsillectomy are the treatments of choice of adenotonsillar 
hypertrophy contributing to OSA. The Childhood Adenotonsillectomy Trial (CHAT study) found 
better outcomes concerning long-term resolution of OSA, with early AT surgery compared with 
watchful waiting (Mitchell, 2015). For this reason, AT is seen as the first line treatment of choice 
for children with diagnosed OSA and clinical symptoms. Withholding treatment, however, may 
be appropriate for those with only mild symptoms and low AHI numbers. Following the peak of 
lymphatic tissue growth between ages 2-8, the tissue atrophies back to a more normal size (Vale, 
2017).  
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Uvulopalatopharyngoplasty, a surgical procedure where soft tissue of the pharynx is 
removed or reshaped, is not recommended at this time. Studies evaluating the effectiveness of 
these methods only shows at most, a 50% decrease in AHI, and in only 50% of those patients 
treated (Caples, 2010). In patients with dysmorphic jaws, maxillomandibular advancement 
(MMA) has been proven to provide resolution of OSA with few side-effects (Spinzia, 2017).  
1.7.3 Positive Airway Pressure 
Positive airway pressure (PAP) is the gold standard treatment for OSA in adults. This type 
of non-invasive ventilation overcomes the negative pressure built up by the diaphragm during 
inhalation and prevents the pharyngeal muscles from collapsing inward. Additionally, PAP can 
increase the pharyngeal volume; decreasing the propensity for airway collapse (Paiva, 2014). For 
children in whom adenotonsillectomy is contraindicated or insufficient for resolution, Continuous 
PAP or CPAP may be titrated and applied. These appliances remain uncomfortable for patients 
making cooperation less than ideal in most cases.  
1.7.4 Oral Appliances 
Dental protrusion devices are used to mechanically enlarge the pharyngeal cross-section 
during sleep. By advancing the mandible, the tongue and other soft tissue which would normally 
impinge on the airway are moved to a more anterior position, away from the airway. The appliance 
functions by attaching to the maxillary and mandibular jaws intraorally and forcing the lower jaw 
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to protrude in relation to the maxilla. These devices are recommended in patients with primary 
snoring, in patients with mild to moderate OSAS who prefer appliances, and in those who do not 
respond to or cannot tolerate CPAP. 
In 1860, RME therapy was first published as an orthodontic correction of maxillary 
constriction. This dental device is placed into the patient’s maxilla and turned via a jack screw to 
increase the size of the patient’s maxilla. This therapy was first linked to SDB, when it was shown 
to decrease nocturnal enuresis in children (Huynh, 2015). A number of smaller studies have 
demonstrated a significant and clinically relevant decrease in AHI after rapid maxillary expansion. 
If RME is performed early enough, nasal breathing may resume which may render 















Purpose of the Present Study 
The purpose of this study is to discover whether RME leads to an improvement in sleep 
quality and a reduction in the signs and symptoms of OSA. Previous low-level studies have 
identified a correlation between RME and AHI. This study aims to be the first high level 
randomized controlled clinical trial to provide a correlation between RME and measures of sleep 
quality as measured by a Home Sleep Test .  
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2.0 Materials and Methods 
2.1 Assurances 
An application for a full Board review was filed with the University of Pittsburgh 
Institutional Review Board. The research council approved the study design and methods for this 
randomized controlled crossover study and assigned the study to a category of minimal risk to the 
patient. 
2.2 Sampling 
A power analysis performed before sample allocation showed that 12 subjects would be 
needed to generalize the results of this study to the general population. A power of 80%, alpha of 
0.05, and effect size were chosen. The effect size was taken from the existing literature concerning 
rapid maxillary expansion and was set at 10 units of AHI.  
2.3 Inclusion / Exclusion Criteria 
Inclusion criteria included patients between the ages of 12 and 16 who were at risk for 
clinically-significant SDB as revealed through the Pediatric Sleep Questionnaire (PSQ).  These 
subjects presented with a noncontributory medical history other than the possibility of sleep 
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disordered breathing. Exclusion criteria included previous orthodontic therapy, previous rapid 
maxillary expansion therapy and any previously diagnosed medical syndrome.  
2.4 Steps to Control Bias 
Randomization was completed using a pre-determined, computer generated, separating 
algorithm (graphpad) which allocated patients into two equal groups for the control and treatment. 
The clinicians which placed the expanders were unable to be blinded as they could physically see 
the appliance. After the information from the sleep studies were gathered and de-identified it was 
given to a specialist statistician for interpretation and analysis. The statistician was blinded to 
which subjects were part of the control or treatment group. 
2.5 Research Methodology 
To gain interest in the study, an IRB-approved research poster was placed at two locations 
inside the private practice of GKG Orthodontics. This poster asks parents if they were “Concerned 
About Your Child’s Sleep?  Ask About Our Research Study!”.  All new patients at the private 
practice of GKG Orthodontics are given a Pediatric Sleep Questionnaire (PSQ) as part of their 
medical history forms. From previous research, a patient with eight or more “yes” answers on the 
PSQ is at risk for sleep disordered breathing (Peña-Zarza, 2012). All patients with positive PSQ 
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are counseled as to the possible meaning (SDB) of these results by the clinicians at GKG and asked 
if they would like to join a sleep study. When a parent or guardian shows interest in the study, a 
separate appointment is made with Dr. Peter Sulaiman. At the following appointment in a private 
office, the subject is screened for inclusion and exclusion criteria. All parts of the study are 
explained thoroughly and the parent is asked if they would consider taking part in the research. 
When parents agree to enrollment, all questions and concerns are answered and a consent form is 
signed by the parent and subject. Instructions for the WatchPAT home sleep test device are given. 
The subject is then randomly allocated into either the treatment or control group using a computer-
generated separating algorithm. This algorithm replicates the separating process of placing six red 
cards (treatment group) and six blue cards (control group) into a hat and randomly drawing one 
for each subject who agrees to study inclusion. Patients in both groups will be analyzed via 
watchPAT and their pre-treatment (T1) data recorded. Guardians will place the device on the 
patient before bedtime and remove the device after the child wakes up. Parameters measured by 
the device include total sleep time (TST), % REM of sleep time, % light sleep time, % deep sleep 
time, respiratory disturbance index (RDI), apnea hypopnea index (AHI), oxygen desaturation 
index (ODI), % sleep time in supine position, % sleep time in non-supine position, supine RDI, 
supine AHI, supine ODI, oxygen saturation minimum, % time spent under 90% oxygen saturation, 
% time spent snoring louder than 45 decibels. The data collected by the WatchPAT device will be 
stored on a password protected/HIPPA compliant server of the PI and given to Dr. Ryan Soose 
upon completion of the study.  
Soon after their T1 data collection, the patients allocated to the treatment group will be 
fitted with bonded type rapid maxillary expanders by Dr. John Grady and an orthodontic assistant. 
The expanders will be fabricated by taking an impression of the patient's maxillary arch using 
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alginate impression material. This impression will be sent to an orthodontic lab to have a custom 
fit expander produced. The RME will be cemented onto the patient's dentition using glass ionomer 
temporary cement. Maxillary expansion will be performed daily by the subjects parent or guardian, 
with one activation of the expansion screw five times each week for a three month period.  Patients 
will  return to the office of GKG Orthodontics for evaluation by Dr. John Grady. After completion 
of expansion, a post-treatment (T2) WatchPAT session will be undertaken and data stored in the 
data server.  Analysis will be performed on the treatment group T1-T2 sample to evaluate the 
changes in the parameters previously discussed. Bonded expanders will be left in place 3 additional 
months to allow the bone to consolidate. At the 3-month stabilization benchmark, a third 
WatchPAT analysis will be performed again (T3) and the RMEs will be removed from the 
treatment group. The protocols for the control and treatment groups will now be reversed. Those 
subjects allocated to the control group for the purpose of “watchful waiting” will have a T1 
WatchPAT study completed after consents have been signed. The results of this study will be 
stored with the other results, on the password protected server of the PI.  Following the study, 
subjects in this group will wait three months without any treatment (expander) and have a T2 
WatchPAT study performed at the completion of the three month waiting period. After the 
WatchPAT study has been logged, these subjects will be fitted with a rapid maxillary expander 
and asked to turn the appliance according to the previously described protocol. A final T3 
WatchPAT study was performed at the completion of the turning regimen.  
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2.6 Outcome Measures 
Change in sleep quality as measured by multiple variables of the WatchPAT sleep study. 
The data obtained from the WatchPAT will include total sleep time (TST), % REM of sleep time, 
% light sleep time, % deep sleep time, respiratory disturbance index (RDI), apnea hypopnea index 
(AHI), oxygen desaturation index (ODI), % sleep time in supine position, % sleep time in non-
supine position, supine RDI, supine AHI, supine ODI, oxygen saturation minimum, % time spent 
under 90% oxygen saturation, % time spent snoring louder than 45 decibels.. The major outcome 
variable will be the change in AHI before and after rapid maxillary expansion treatment. 
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3.0 Results  
Among the control group subjects, total sleep time increased from an average of 7.48 hours 
to 8.04 hours after a 3 month period (Figure 3). Percent REM sleep increased 9.53% from a 
baseline of 27.0% to 29.58% at T2. Percent light sleep stayed relatively unchanged at 50% of total 
sleep time. The percent of time spent in deep sleep decreased from 22.60% of the night to 19.95%. 
Respiratory disturbance index decreased from 12.24 to 9.95, AHI increased from 3.86 to 4.20, and 
ODI decreased from 1.50 episodes per hour of sleep to 0.90 episodes after 3 months. Oxygen 
saturation increased from an average of 90.40% to 93.00%. The percent of sleep time spent supine 
was 41.80 percent and 58.18 percent non supine. at baseline. At T2 these values were 49.15 and 
50.80 respectively. Supine RDI decreased slightly from 11.72 to 11.50. Supine AHI increased from 












Figure 3: Control Group Differences 
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93.98% decrease. Snoring, measured as noise over 45 decibels, increased from 4.98 percent 
of the night on average to 9.10%. 
The treatment group’s average total sleep time increased from an average of 6.44 hours to 
7.63 hours after treatment (Figure 4). Percent REM sleep decreased 7.72% from a baseline of 
24.0% to 22.15% at T2. Percent light sleep fell 10.27% from 49.32 to 44.25. One of the larger 
increases in the data from T1 to T2 was the percent of time spent in deep sleep. At T1, the treatment 
group averaged 26.68% deep sleep and 33.60% after treatment. Respiratory disturbance index 
decreased from 9.53 to 6.30, AHI decreased from 2.47 to 2.10, and ODI decreased from 1.03 
Figure 4: Treatment Group Differences 
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episodes per hour of sleep to 0.50 episodes after expansion therapy. Oxygen saturation minimum 
increased from an average of 90.67% to 93.00%. The percent of sleep time spent supine was 47.47 
percent and 52.53 percent non supine. at baseline. At T2 these values were 18.10 and 81.90 
respectively; a change of over 50%.  Supine RDI decreased from 6.37 to 5.90. Supine AHI 
increased very slightly from 2.10 episodes per hour on average to 2.20 episodes. Supine ODI 
decreased 100% with our data set. Baseline ODI for the treatment group was 0.97. Average ODI 
at T2 was 0.00 episodes  per hour of sleep. Snoring decreased from 2.57 percent of the night on 





Table 4: Study Data 
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4.0 Discussion 
Data was separated into two groups. Group 1 consists of only the numerical scores for the 
subjects in the control phase. As previously stated, subjects randomized to the control group had a 
baseline sleep study and a final study 3 months later. The purpose of this control group was 
twofold. First, to be used as a baseline to compare against the results of the treatment group; and 
two: to determine if sleep parameters remain consistent over time or change. Table 4 shows the 
percent change of various parameters from T1 to T2. The apnea hypopnea index was the main 
variable of comparison. Of interest is a slight increase in AHI for the control group from a baseline 
average of 3.86 to 4.20 after a 3 month waiting period. The treatment group, however, showed a 
14.86% decrease in AHI. Impressions from limited data indicate a slight worsening of sleep quality 
over time for untreated controls and a modest increase in sleep quality for subjects treated with 
rapid maxillary expansion. This finding is consistent with anecdotal and low level studies 
published on the effect of RME on AHI.  
Of further interest is an apparent shift from light to deep sleep. Over 3 months, controls 
showed a substantial decrease in time spent in deep sleep. Treated subjects showed a decrease in 
the percentage of time spent in light (transient) sleep stages with a large increase in the amount of 
time spent in deep sleep stages. 
Snoring is never a normal finding in children. Snoring in children indicates a sleep problem 
of some kind that requires further testing and further evaluation by a trained sleep specialist. In the 
control group we found an increase in snoring from 4.98% of the night to 9.10% over three months 
of watchful waiting without treatment. Conversely, the group treated with expansion therapy had 
a 37.66% decrease in snoring. Further analysis shows an increased positive effect of the treatment 
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group compared to the control. The control group’s average RDI scores decreased 18.71% 
compared to a 33.92% decrease for those treated with expanders. ODI decreased 40.00% for the 
control group and 51.61% for the treated subjects. For most sleep parameters, the treatment group 
outperformed the control group. This is positive news for those seeking to use RME to benefit 
those with sleep disordered breathing. The data in this thesis project shows a positive effect of 
RME on sleep quality compared to untreated controls.  
May I suggest the following: hypertrophy of the adenoids and tonsils leads to a soft tissue 
tube (the pharynx) that is obstructed. Research done by Moss in the dental literature suggests that 
soft tissues and airways play an important role in the formation and shape of hard tissues. In 
essence, "spaces make faces." A normal functioning airway helps in the adaptation and creation of 
a properly formed and useful hard tissue structure. When children are deprived of this normal 
anatomy and diameter of their airways, the hard tissues grow abnormally, leading to a 
dolichocephalic facial form with a high narrow palate and open mouth breathing posture. In these 
children, there are actually 2 concurrent problems. One: the enlarged adenoids and tonsils are 
obstructing a portion of the airway diameter and are preventing normal flow of oxygen. Two: in 
response to this airway, the child's boney tissues have grown abnormally in adaptation to this 
airflow restriction. Recent studies by Lee et.al. actually show that despite T&A treatment, children 
may still present with mouth breathing and elevated AHI (Lee, 2015). Other studies report 20% of 
children still have OSA following T&A. (Tang, 2016) Treatment therefore, is actually twofold. 
First AT surgery should be performed to recreate the normal anatomy of the airway. Second, RME 
should be performed to reproduce normal boney proportions of the maxilla. If caught early enough, 
the idealized airway along with the idealized boney structure should allow the patient to grow in a 
manner so as to make the later diagnosis of sleep apnea unlikely. 
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Limitations of this study are based on the completeness of data collection. During the T2 
and T3 collection timeframe, the coronavirus pandemic shut down most of the country. In line 
with state and local ordinances, all research data collection was put on hold. As a result, much of 
the T2 and T3 data was not obtained. Due to this limitation and to the status as a pilot study, 
conclusions are based on averages without further statistical analysis. All conclusions should be 
regarded as anecdotal until the completion of the data collection and publishing of the final paper. 
This thesis seeks to be the first high level study to find an association between rapid 
maxillary expansion and sleep quality. Previous studies are anecdotal in nature without high level 
research methodology, control groups, or analysis of findings. Although the goals have not been 
met for this thesis, there is hope that this research will be taken to its completion. Further studies 
should focus on cementing the link between rapid maxillary expansion and sleep quality. If a 
positive link is found between the two, it would be helpful to determine if a positive treatment 
effect can be found for younger children, and if that effect maintains itself further into adolescence 
and even adulthood.  
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Appendix A : Figures 
Figure 5: Mallampati Classification 
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Appendix B : Sleep Questionnaires 
Figure 6: Stanford Sleepiness Scale 
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Figure 7: Epworth Sleepiness Scale 
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Figure 8: Pediatric Sleep Questionnaire 
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